Literature DB >> 18403045

Predictors of talc pleurodesis outcome in patients with malignant pleural effusions.

Huseyin Yildirim1, Muzaffer Metintas, Güntülü Ak, Selma Metintas, Sinan Erginel.   

Abstract

OBJECTIVE: Chemical pleurodesis is an accepted palliative therapy for patients with recurrent, symptomatic, malignant pleural effusions (MPE). The purpose of the study was to determine the factors that have an effect on successful pleurodesis for MPE. PATIENTS AND
INTERVENTIONS: Eighty-four consecutive patients with biopsy-proven malignant pleural disease and recurrent, symptomatic MPE were eligible to participate in this study. Five grams of talc mixed in 150ml of normal saline were administered via tube thoracostomy or small-bore catheters after complete drainage of the pleural effusion.
RESULTS: Seven patients did not return for their 30-day follow-up visit and were excluded from further analysis. Successful pleurodesis was achieved in 63 of 77 eligible patients (81.8%) with MPE. In the univariate analysis, female gender, Karnofsky performance status, pleural fluid pH, cholesterol, and adenosine deaminase level showed a significant association with the probability of success. Multivariate logistic regression analysis showed that pleural fluid pH and ADA levels were independent predictors of talc pleurodesis outcome.
CONCLUSION: Our results show that pleurodesis using talc as the sclerosing agent is a simple and acceptable procedure with high efficacy for controlling MPE, especially when used in appropriate patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18403045     DOI: 10.1016/j.lungcan.2008.02.017

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  6 in total

1.  Efficacy and safety of Viscum album extract (Helixor-M) to treat malignant pleural effusion in patients with lung cancer.

Authors:  Yun-Gyoo Lee; Ina Jung; Dong-Hoe Koo; Du-Young Kang; Tae Yoon Oh; Sukjoong Oh; Seung-Sei Lee
Journal:  Support Care Cancer       Date:  2018-09-14       Impact factor: 3.603

2.  The efficacy and safety of intrapleural hyperthermic perfusion in patients with malignant pleural effusion undergoing video-assisted thoracic surgery: a single-arm clinical trial.

Authors:  Xinxin Wang; Min Kong; Jiang Jin; Yulian Lin; Limin Jia; Minhua Ye
Journal:  J Thorac Dis       Date:  2022-05       Impact factor: 3.005

3.  Clinical predictors of successful and earlier pleurodesis with a tunnelled pleural catheter in malignant pleural effusion: a cohort study.

Authors:  Pen Li; Alison Graver; Sarah Hosseini; Sunita Mulpuru; Lorraine Cake; Lynn Kachuik; Tinghua Zhang; Kayvan Amjadi
Journal:  CMAJ Open       Date:  2018-06-13

4.  Pleural effusion adenosine deaminase: a candidate biomarker to discriminate between Gram-negative and Gram-positive bacterial infections of the pleural space.

Authors:  Ruolin Li; Junli Wang; Xinfeng Wang; Maoshui Wang
Journal:  Clinics (Sao Paulo)       Date:  2016-05       Impact factor: 2.365

Review 5.  Contemporary best practice in the management of malignant pleural effusion.

Authors:  Coenraad F N Koegelenberg; Jane A Shaw; Elvis M Irusen; Y C Gary Lee
Journal:  Ther Adv Respir Dis       Date:  2018 Jan-Dec       Impact factor: 4.031

6.  A multidirectional two-tube method for chemical pleurodesis could improve distribution of the sclerosing agent within the pleural cavity - A pilot study.

Authors:  Eoin Campion; Saad I Mallah; Maimoona Azhar; Dara O'Keeffe; Aamir Hameed
Journal:  Ann Med Surg (Lond)       Date:  2021-08-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.